Shilpa Medicare

{
  "main_header": {
    "sid": 780523,
    "name": "Shilpa Medicare",
    "stock_name": "Shilpa Medicare",
    "full_name": "Shilpa Medicare Ltd",
    "name_url": "stocks-analysis/shilpa-medicare",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "437.00",
    "chg": -4.7,
    "chgp": "-1.06%",
    "dir": -1,
    "prev_price": "441.70",
    "mcapval": "8,581.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 530549,
    "symbol": "SHILPAMED",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE790G01031",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "7.16 lacs",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shilpa-medicare-780523-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Shilpa Medicare Gains 4.19%: 6 Key Factors Driving This Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-gains-419-6-key-factors-driving-this-weeks-momentum-3983378",
        "imagepath": "",
        "date": "2026-05-09 15:06:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Week opens at Rs.418.70</p>\n                    <p><strong>5 May:</strong> Technical momentum shifts amid mixed indicator signals; stock rises 1.36%</p>\n                    <p><strong>6 May:</strong> Mojo Grade downgraded to Sell; sideways trend emerges with mixed technicals</p>\n                    <p><strong>7 May:</strong> Mojo Grade upgraded to Hold; technical momentum turns mildly bullish; valuation shifts to expensive</p>\n                    <p><strong>8 May:</strong> Golden Cross formation signals potential bullish breakout; stock closes at Rs.436.25</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"..."
      },
      {
        "title": "Golden Cross Forms in Shilpa Medicare Ltd — On a Day the Stock Fell 1.3%. What the Mixed Signals Mean",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-forms-golden-cross-signalling-potential-bullish-breakout-3982279",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ShilpaMedicareL_goldencross_3982279.png",
        "date": "2026-05-08 18:00:24",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Shilpa Medicare Ltd, signalling a golden cross on 8 Jun 2026. Yet, the stock declined 1.26% on the day this technical event occurred, while monthly momentum indicators remain mildly bearish. This juxtaposition of signals calls for a detailed examination of whether the golden cross stands on firm ground or is contradicted by other data."
      },
      {
        "title": "Shilpa Medicare Ltd Upgraded to Hold on Technical and Valuation Shifts",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-upgraded-to-hold-on-technical-and-valuation-shifts-3979060",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ShilpaMedicareL_mojoScore_3979060.png",
        "date": "2026-05-07 08:19:58",
        "description": "Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 6 May 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautiously optimistic outlook for investors."
      },
      {
        "title": "Shilpa Medicare Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-3978885",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ShilpaMedicareL_technicaldot_3978885.png",
        "date": "2026-05-07 08:04:36",
        "description": "Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bullish phase. This change is underscored by mixed signals from key technical indicators, alongside impressive stock returns that have outpaced the broader Sensex over multiple timeframes."
      },
      {
        "title": "Shilpa Medicare Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-valuation-shifts-signal-changing-market-sentiment-3978717",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ShilpaMedicareL_valuationdot_3978717.png",
        "date": "2026-05-07 08:01:35",
        "description": "Shilpa Medicare Ltd has witnessed a notable shift in its valuation parameters, moving from fair to expensive territory, even as its stock price continues to outperform the broader market. With a current price of ₹442.10 and a recent day gain of 4.17%, the pharmaceutical and biotechnology company’s valuation metrics now demand closer scrutiny against historical and peer benchmarks."
      },
      {
        "title": "Shilpa Medicare Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3976884",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ShilpaMedicareL_technicaldot_3976884.png",
        "date": "2026-05-06 08:04:10",
        "description": "Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a 1.36% gain on 6 May 2026, the stock’s technical indicators present a complex picture, with bullish signals on some timeframes and bearish or neutral cues on others, prompting a recent downgrade in its Mojo Grade from Hold to Sell."
      },
      {
        "title": "Shilpa Medicare Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3974859",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ShilpaMedicareL_technicaldot_3974859.png",
        "date": "2026-05-05 08:04:59",
        "description": "Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a 2.9% gain on 5 May 2026, the stock’s technical indicators present a complex picture, with bullish signals on some timeframes and bearish cues on others, prompting a recent downgrade in its Mojo Grade from Hold to Sell."
      },
      {
        "title": "Shilpa Medicare Declines 1.67% Despite Mixed Signals: 2 Key Factors Behind the Week’s Movement",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-declines-167-despite-mixed-signals-2-key-factors-behind-the-weeks-movement-3971654",
        "imagepath": "",
        "date": "2026-05-02 15:04:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Apr:</strong> MarketsMOJO downgrades Shilpa Medicare to Sell</p>\n                    <p><strong>28 Apr:</strong> Technical momentum shifts amid mixed indicator signals</p>\n                    <p><strong>30 Apr:</strong> Week closes at Rs.406.90 (-1.67%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.413.80</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.406.90</div><div class=\"stat-change negative\">-1.67%</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-l..."
      },
      {
        "title": "Shilpa Medicare Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3965884",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShilpaMedicareL_mojoScore_3965884.png",
        "date": "2026-04-28 08:31:57",
        "description": "Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 27 Apr 2026. This revision reflects a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments that collectively signal caution for investors despite recent positive quarterly results."
      }
    ],
    "total": 397,
    "sid": "780523",
    "stock_news_url": "https://www.marketsmojo.com/news/shilpa-medicare-780523"
  },
  "announcements": [
    {
      "details": "Shilpa Medicare Limited has informed the Exchange regarding Disclosure of Related Party Transaction disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Shilpa Medicare Limited - Other General Purpose",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Shilpa Medicare Limited has informed the Exchange regarding Board meeting held on November 09, 2019.",
      "source": "NSE",
      "caption": "Shilpa Medicare Limited - Outcome of Board Meeting",
      "datetime": "13-Nov-2019"
    },
    {
      "details": "Shilpa Medicare Limited has informed the Exchange regarding ''.",
      "source": "NSE",
      "caption": "Shilpa Medicare Limited - Updates",
      "datetime": "06-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shilpa Medicare Ltd has declared <strong>100%</strong> dividend, ex-date: 17 Sep 25",
          "dt": "2025-09-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shilpa Medicare Ltd has announced <strong>1:2</strong> stock split, ex-date: 06 Nov 15",
          "dt": "2015-11-06",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shilpa Medicare Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 03 Oct 25",
          "dt": "2025-10-03",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Shilpa Medicare Gains 4.19%: 6 Key Factors Driving This Week’s Momentum

2026-05-09 15:06:19

Key Events This Week

4 May: Week opens at Rs.418.70

5 May: Technical momentum shifts amid mixed indicator signals; stock rises 1.36%

6 May: Mojo Grade downgraded to Sell; sideways trend emerges with mixed technicals

7 May: Mojo Grade upgraded to Hold; technical momentum turns mildly bullish; valuation shifts to expensive

8 May: Golden Cross formation signals potential bullish breakout; stock closes at Rs.436.25

Read full news article

Golden Cross Forms in Shilpa Medicare Ltd — On a Day the Stock Fell 1.3%. What the Mixed Signals Mean

2026-05-08 18:00:24

The 50-day moving average has crossed above the 200-day moving average for Shilpa Medicare Ltd, signalling a golden cross on 8 Jun 2026. Yet, the stock declined 1.26% on the day this technical event occurred, while monthly momentum indicators remain mildly bearish. This juxtaposition of signals calls for a detailed examination of whether the golden cross stands on firm ground or is contradicted by other data.

Read full news article

Shilpa Medicare Ltd Upgraded to Hold on Technical and Valuation Shifts

2026-05-07 08:19:58

Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 6 May 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautiously optimistic outlook for investors.

Read full news article

Shilpa Medicare Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook

2026-05-07 08:04:36

Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bullish phase. This change is underscored by mixed signals from key technical indicators, alongside impressive stock returns that have outpaced the broader Sensex over multiple timeframes.

Read full news article

Shilpa Medicare Ltd Valuation Shifts Signal Changing Market Sentiment

2026-05-07 08:01:35

Shilpa Medicare Ltd has witnessed a notable shift in its valuation parameters, moving from fair to expensive territory, even as its stock price continues to outperform the broader market. With a current price of ₹442.10 and a recent day gain of 4.17%, the pharmaceutical and biotechnology company’s valuation metrics now demand closer scrutiny against historical and peer benchmarks.

Read full news article

Shilpa Medicare Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-06 08:04:10

Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a 1.36% gain on 6 May 2026, the stock’s technical indicators present a complex picture, with bullish signals on some timeframes and bearish or neutral cues on others, prompting a recent downgrade in its Mojo Grade from Hold to Sell.

Read full news article

Shilpa Medicare Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-05 08:04:59

Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a 2.9% gain on 5 May 2026, the stock’s technical indicators present a complex picture, with bullish signals on some timeframes and bearish cues on others, prompting a recent downgrade in its Mojo Grade from Hold to Sell.

Read full news article

Shilpa Medicare Declines 1.67% Despite Mixed Signals: 2 Key Factors Behind the Week’s Movement

2026-05-02 15:04:36

Key Events This Week

27 Apr: MarketsMOJO downgrades Shilpa Medicare to Sell

28 Apr: Technical momentum shifts amid mixed indicator signals

30 Apr: Week closes at Rs.406.90 (-1.67%)

Week Open

Rs.413.80

Week Close

Rs.406.90

-1.67%

Read full news article

Shilpa Medicare Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-04-28 08:31:57

Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 27 Apr 2026. This revision reflects a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments that collectively signal caution for investors despite recent positive quarterly results.

Read full news article

View All News